Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.

Brebi P, Ili CG, Andana A, Menzel D, Lopez J, Guzman P, Melo A, Buchegger K, Roa JC.

BMC Cancer. 2017 Aug 3;17(1):518. doi: 10.1186/s12885-017-3496-x.

2.

Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.

Brebi P, Hoffstetter R, Andana A, Ili CG, Saavedra K, Viscarra T, Retamal J, Sanchez R, Roa JC.

Biomarkers. 2014 May;19(3):181-8. doi: 10.3109/1354750X.2013.867535.

PMID:
24787227
3.

Cellular FLICE-like inhibitory protein long form (c-FLIPL) overexpression is related to cervical cancer progression.

Ili CG, Brebi P, Tapia O, Sandoval A, Lopez J, Garcia P, Leal P, Sidransky D, Guerrero-Preston R, Roa JC.

Int J Gynecol Pathol. 2013 May;32(3):316-22. doi: 10.1097/PGP.0b013e31825d8064.

PMID:
23518915
4.

Genotyping of human papillomavirus in cervical intraepithelial neoplasia in a high-risk population.

Ili CG, Brebi P, López J, García P, Leal P, Suarez E, Roa JC.

J Med Virol. 2011 May;83(5):833-7. doi: 10.1002/jmv.22057. Epub 2011 Feb 25.

PMID:
21360550

Supplemental Content

Support Center